This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Max-Delbruck-Centrum Fur Molekulare Medizin, Max-Delbruck-Centrum Fur Molekulare Medizin in Der Helmholtz-Gemeinschaft, Universidade Federal De Minas Gerais. Active years: 2013-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 32 
1 out of 23 
1 out of 43 
Years Active: 2013-2022
Title: The Innovative Journey of Natalia Alenina
Introduction
Natalia Alenina, an accomplished inventor based in Berlin, Germany, has made significant contributions to the field of biomedical sciences. With two patents to her name, her innovative methods focus on advanced treatments for various health conditions, showcasing her expertise and dedication to improving human health.
Latest Patents
Natalia's latest patents reflect her commitment to creating effective therapeutic modalities. One of her significant inventions is a method for modulating pigmentation through angiotensin-converting enzyme 2 (ACE2) modulation. This cosmetic method enables the administration of ACE2 modulators, which can either enhance or decrease pigmentation based on the specific needs of the subject. Additionally, her second patent involves the use of Mas-G-protein-coupled receptor agonists for the modulation, treatment, and prevention of metabolic syndrome. This innovative approach targets body levels of triglycerides, cholesterol, and glucose, along with hypertension and weight issues, highlighting her focus on addressing complex health challenges.
Career Highlights
Throughout her career, Natalia has worked with esteemed institutions, including the Max Delbrück Center for Molecular Medicine, where she has gained invaluable experience in her field. Her inventive spirit and research prowess have propelled her to the forefront of biomedical innovation.
Collaborations
Natalia has collaborated with notable professionals such as Michael Bader and Fatimunnisa Qadri, further enriching her contributions to the scientific community. These partnerships have enabled her to refine her inventions and enhance their applicability in real-world scenarios.
Conclusion
Natalia Alenina stands out as a pioneering inventor whose work has the potential to revolutionize treatments for pigmentation issues and metabolic syndrome. With an impressive portfolio of patents and robust collaborations, she continues to be an influential figure in the realm of biomedical innovations. Her relentless pursuit of knowledge and improvement positions her as a key contributor to future advancements in health science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile